The largest database of trusted experimental protocols

6 protocols using jwh 018

1

Cannabinoid Dose Conversion for Humans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Δ9-THC was provided by Dr. S. Morimoto (Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan) and stored in ethanol at −80 °C. JWH-018, metabolites of JWH-018, deuterium-labelled JWH-018 (JWH-018-d9) and AM-251 were purchased from Cayman Chemical (Ann Arbor, MI, USA) and stored at −20 °C. The doses of cannabinoids presently used here were selected based on the CB1R affinity of the ligands and the electrographic representation of mild seizure events. In fact, we intentionally selected relatively high doses that we knew to have an effect on EEG power spectra39 (link). The conversion of an animal to human dose cannot be done directly, as in the few available studies on human volunteers most utilize the inhalation route, while we administered drugs intraperitoneally. However, after applying the human estimation dose conversion40 (link), 2.5 mg/kg of JWH-018 in mouse corresponds to 0.2 mg/kg, or roughly 12 mg per person. Similarly, 10 mg/kg of ∆9-THC in mice converts to 0.8 mg/kg in humans or about 49 mg per individual.
+ Open protocol
+ Expand
2

Characterization of Synthetic Cannabinoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
All solvents were high-performance liquid chromatography (HPLC) grade, purchased from Fisher Scientific (Fair Lawn, NJ), EMD Chemical (Gibbstown, NJ), and Sigma-Aldrich (St. Louis, MO). JWH-018, AM2201, JWH-122, UR144, XLR11, and 5F-AKB48 reference standards were obtained from Cayman Chemical (Ann Arbor, MI). JWH-019 reference standard was synthesized in the laboratory of Dr. John W. Huffman and provided by Dr. Jenny L. Wiley. Herbal products were obtained from the Richland County Sheriff’s Department (Columbia, SC). These products were seized between December 2011 and August 2013 and were scheduled for destruction. Custody was turned over to RTI International, and products were stored in accordance with established protocols.
+ Open protocol
+ Expand
3

Comprehensive Cannabinoid Pharmacology Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The native phytocannabinoids Δ9-tetrahydrocannabinol (Δ9-THC, also called dronabinol, psychoactive high affinity CB1 and CB2 agonist) and cannabidiol (non-psychoactive, very low affinity CB1 and CB2 indirect antagonist thought to attenuate the action of Δ9-THC) were obtained from Cayman Chemical (Ann Arbor, MI). Synthetic cannabinoids obtained from Cayman Chemical (Ann Arbor, MI) were as follows: dronabinol (also called Δ9-tetrahydrocannabinol or Δ9-THC; high affinity CB1 and CB2 agonist), HU-210 (potent CB1 and CB2 receptor agonist analogue of Δ9-THC), JWH 018 (high affinity CB1 and CB2 ligand, mildly selective for CB2); Rimonabant high affinity selective CB1 receptor inverse agonist), JWH-133 (high affinity, 200-fold selective CB2 agonist), SR-144528 (high affinity CB2 inverse agonist), CP55,940 (high affinity non-selective CBR agonist, more potent than Δ9-THC). Synthetic cannabinoids that inhibit AEA uptake without affecting AEA hydrolysis (AM404), inhibit AEA uptake and weakly inhibit AEA hydrolysis (OMD1, OMD2), or inhibit AEA hydrolysis (VDM11) were purchased from Cayman Chemical (Ann Arbor, MI). BMS309403, known to bind/inhibit other FABPs (FABP3,4,5,7) was obtained from Cayman Chemical (Ann Arbor, MI). SCP2 inhibitors (SCPI1, SCPI3, and SCPI4) were from ChemBridge Corporation (San Diego, CA).
+ Open protocol
+ Expand
4

Comprehensive Cannabinoid Compound Acquisition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following compounds were purchased from Cayman Chemical: 4-fluoro MDMB-BUTINACA, 5-fluoro MDMB-PICA, AB-FUBINACA, AM1220, AM1248, JWH-018, JWH-122 N-(5-chloropentyl), MDMB-4en-PINACA, WIN 55,212-2, UR-144, XLR-11, anandamide (AEA) and JWH-133. Capsaicin was obtained from Sigma-Aldrich (St. Louis, MO). Controlled substances were purchased using the Walsh Laboratory DEA license.
+ Open protocol
+ Expand
5

Pharmacokinetics of Synthetic Cannabinoid

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals used in this study were at least reagent grade. JWH-018 ((1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone) was purchased from Cayman Chemical (Ann Arbor, MI). Unless otherwise specified, all chemicals and reagents were purchased from either Sigma-Aldrich (St. Louis, MO) or Thermo Fisher Scientific (Waltham, MA). Ethyl alcohol (100%) was purchased from AAPER (Shelbyville, KY). Recombinant CYP2C9*1, CYP2C9*2 and CYP2C9*3 were expressed in baculovirus-infected insect cells and purchased from BD Biosciences (San Jose, CA).
+ Open protocol
+ Expand
6

Synthetic Cannabinoids and Drug Standards Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standards of synthetic cannabinoids JWH 018, JWH 073, AM 1220 and WIN 55 were purchased from Cayman Chemical (Ann Arbor, MI, USA) at a concentration of 1 or 0.1 mg mL -1 based on availability. Standards of cocaine (COC), phencyclidine (PCP), morphine (MOR) and methamphetamine (MAMP) were purchased from LGC Standard (Italy). The purity of the reference compounds was > 99%. All standards were provided at a concentration of 3 mM. Individual stock solutions were prepared in methanol at 300 μM and working standard mixtures were prepared by appropriate dilution of the standard solutions in methanol. All solutions were stored at -20 °C in dark condition. All buffer reagents, methanol, acetonitrile and water were acquired from Fisher Scientific (Fair Lawn, NJ, USA). All solvents employed in the extraction were ultra-performance liquid chromatography (UPLC) grade, and LC-MS grade.
The solid phase extraction sorbent materials VYWLVW-resin (W) and YYIGGF-resin (F), with a peptide substitution level of 0.17 mmol g -1 and a synthesis reproducibility > 95%. were bought from EspiKem srl (Italy). The resin used to attach the hexapeptides was a Fmoc-PAL-AM. The C-18 cartridges (30 mg mL -1 ) were from Phenomenex. SPE Isolute column (Empty 1 mL Reservoir) was from STEPBIO (Italy).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!